Integrative analysis of genes and miRNA alterations in human embryonic stem cells-derived neural cells after exposure to silver nanoparticles

Toxicology and Applied Pharmacology

Volumn 299, Issue , 2016, Pages 8-23

  Oh, Jung Hwa ^a,b   Son, Mi Young ^b,c   Choi, Mi Sun ^a   Kim, Soojin ^a   Choi, A young ^a   Lee, Hyang Ae ^a,b   Kim, Ki Suk ^a,b   Kim, Janghwan ^b,c   Song, Chang Woo ^a,b   Yoon, Seokjoo ^a,b  

^a Korea Institute of Toxicology   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Developmental neurotoxicity; Gene expression profiling; Human embryonic stem cells derived neural cells; miRNA profiling; Nanotoxicity; Silver nanoparticles

Indexed keywords

LACTATE DEHYDROGENASE; MICRORNA; SILVER NANOPARTICLE; METAL NANOPARTICLE; SILVER;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL VIABILITY; CYTOTOXICITY; DISEASE ASSOCIATION; DOSE RESPONSE; ELECTROPHYSIOLOGICAL PROCEDURES; FLOW CYTOMETRY; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN EMBRYONIC STEM CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; ANIMAL; CELL SURVIVAL; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION STUDY; GENETICS; MOUSE; NEURAL STEM CELL; PHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION STUDIES; HUMAN EMBRYONIC STEM CELLS; HUMANS; METAL NANOPARTICLES; MICE; MICRORNAS; NEURAL STEM CELLS; SIGNAL TRANSDUCTION; SILVER;

EID: 84947484110     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2015.11.004     Document Type: Article

References (80)

1. Ahamed M., Alsalhi M.S., Siddiqui M.K. Silver nanoparticle applications and human health. Clinica chimica acta. Int. J. Clin. Chem. 2010, 411:1841-1848.
2. Anson B.D., Kolaja K.L., Kamp T.J. Opportunities for use of human iPS cells in predictive toxicology. Clin. Pharmacol. Ther. 2011, 89:754-758.
3. Asharani P.V., Hande M.P., Valiyaveettil S. Anti-proliferative activity of silver nanoparticles. BMC Cell Biol. 2009, 10:65.
4. AshaRani P.V., Low Kah Mun G., Hande M.P., Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009, 3:279-290.
5. Bal-Price A.K., Hogberg H.T., Buzanska L., Lenas P., van Vliet E., Hartung T. In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints. Neurotoxicology 2010, 31:545-554.
6. Bourdon J.A., Halappanavar S., Saber A.T., Jacobsen N.R., Williams A., Wallin H., Vogel U., Yauk C.L. Hepatic and pulmonary toxicogenomic profiles in mice intratracheally instilled with carbon black nanoparticles reveal pulmonary inflammation, acute phase response, and alterations in lipid homeostasis. Toxicol. Sci. 2012, 127:474-484.
7. Braydich-Stolle L., Hussain S., Schlager J.J., Hofmann M.C. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol. Sci. 2005, 88:412-419.
8. Burch W.M. Passage of inhaled particles into the blood circulation in humans. Circulation 2002, 106:e141-e142. (author reply e141-142).
9. Carlson C., Hussain S.M., Schrand A.M., Braydich-Stolle L.K., Hess K.L., Jones R.L., Schlager J.J. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J. Phys. Chem. B 2008, 112:13608-13619.
10. Charlwood J., Skehel J.M., King N., Camilleri P., Lord P., Bugelski P., Atif U. Proteomic analysis of rat kidney cortex following treatment with gentamicin. J. Proteome Res. 2002, 1:73-82.
11. Clark J.E., Foresti R., Green C.J., Motterlini R. Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem. J. 2000, 348(Pt 3):615-619.
12. Clichici S., Mocan T., Filip A., Biris A., Simon S., Daicoviciu D., Decea N., Parvu A., Moldovan R., Muresan A. Blood oxidative stress generation after intraperitoneal administration of functionalized single-walled carbon nanotubes in rats. Acta Physiol. Hung. 2011, 98:231-241.
13. Cui Y., Liu H., Ze Y., Zengli Z., Hu Y., Cheng Z., Cheng J., Hu R., Gao G., Wang L., Tang M., Hong F. Gene expression in liver injury caused by long-term exposure to titanium dioxide nanoparticles in mice. Toxicol. Sci. 2012, 128:171-185.
14. de Lima R., Seabra A.B., Duran N. Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles. J. Appl. Toxicol. 2012, 32:867-879.
15. Dhawan A., Sharma V. Toxicity assessment of nanomaterials: methods and challenges. Anal. Bioanal. Chem. 2010, 398:589-605.
16. Donaldson K. Resolving the nanoparticles paradox. Nanomedicine (Lond.) 2006, 1:229-234.
17. Elder A., Gelein R., Silva V., Feikert T., Opanashuk L., Carter J., Potter R., Maynard A., Ito Y., Finkelstein J., Oberdorster G. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ. Health Perspect. 2006, 114:1172-1178.
18. 2 nanoparticles via p38-Nrf-2 signaling pathway in human bronchial epithelial cell, Beas-2B. Toxicol. Lett. 2009, 187:77-83.
19. Finkel T. Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 2003, 15:247-254.
20. Foldbjerg R., Dang D.A., Autrup H. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch. Toxicol. 2011, 85:743-750.
21. Frohlich E., Meindl C., Wagner K., Leitinger G., Roblegg E. Use of whole genome expression analysis in the toxicity screening of nanoparticles. Toxicol. Appl. Pharmacol. 2014, 280:272-284.
22. Fulda S., Gorman A.M., Hori O., Samali A. Cellular stress responses: cell survival and cell death. Int. J. Cell Biol. 2010, 2010:214074.
23. Garcia S.J., Seidler F.J., Crumpton T.L., Slotkin T.A. Does the developmental neurotoxicity of chlorpyrifos involve glial targets? Macromolecule synthesis, adenylyl cyclase signaling, nuclear transcription factors, and formation of reactive oxygen in C6 glioma cells. Brain Res. 2001, 891:54-68.
24. Gottschall P.E., Howell M.D. ADAMTS expression and function in central nervous system injury and disorders. Matrix Biol. 2015.
25. Grzincic E.M., Yang J.A., Drnevich J., Falagan-Lotsch P., Murphy C.J. Global transcriptomic analysis of model human cell lines exposed to surface-modified gold nanoparticles: the effect of surface chemistry. Nanoscale 2015, 7:1349-1362.
26. Hackenberg S., Scherzed A., Kessler M., Hummel S., Technau A., Froelich K., Ginzkey C., Koehler C., Hagen R., Kleinsasser N. Silver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Toxicol. Lett. 2011, 201:27-33.
27. Halappanavar S., Saber A.T., Decan N., Jensen K.A., Wu D., Jacobsen N.R., Guo C., Rogowski J., Koponen I.K., Levin M., Madsen A.M., Atluri R., Snitka V., Birkedal R.K., Rickerby D., Williams A., Wallin H., Yauk C.L., Vogel U. Transcriptional profiling identifies physicochemical properties of nanomaterials that are determinants of the in vivo pulmonary response. Environ. Mol. Mutagen. 2015, 56:245-264.
28. Hartung T. Food for thought . . . on cell culture. ALTEX 2007, 24:143-152.
29. Hartung T. Food for thought . . . on animal tests. ALTEX 2008, 25:3-16.
30. Hartung T., Daston G. Are in vitro tests suitable for regulatory use?. Toxicol. Sci. 2009, 111:233-237.
31. Heng B.C., Richards M., Shu Y., Gribbon P. Induced pluripotent stem cells: a new tool for toxicology screening?. Arch. Toxicol. 2009, 83:641-644.
32. Hoelting L., Scheinhardt B., Bondarenko O., Schildknecht S., Kapitza M., Tanavde V., Tan B., Lee Q.Y., Mecking S., Leist M., Kadereit S. A 3-dimensional human embryonic stem cell (hESC)-derived model to detect developmental neurotoxicity of nanoparticles. Arch. Toxicol. 2013, 87:721-733.
33. Hornby R.J., Starkey Lewis P., Dear J., Goldring C., Park B.K. MicroRNAs as potential circulating biomarkers of drug-induced liver injury: key current and future issues for translation to humans. Expert. Rev. Clin. Pharmacol. 2014, 7:349-362.
34. Hussain S.M., Hess K.L., Gearhart J.M., Geiss K.T., Schlager J.J. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. In Vitro 2005, 19:975-983.
35. Hussain S.M., Javorina A.K., Schrand A.M., Duhart H.M., Ali S.F., Schlager J.J. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol. Sci. 2006, 92:456-463.
36. Jiao Z.H., Li M., Feng Y.X., Shi J.C., Zhang J., Shao B. Hormesis effects of silver nanoparticles at non-cytotoxic doses to human hepatoma cells. PLoS One 2014, 9.
37. Kagan V.E., Bayir H., Shvedova A.A. Nanomedicine and nanotoxicology: two sides of the same coin. Nanomedicine 2005, 1:313-316.
38. Kahru A., Dubourguier H.C. From ecotoxicology to nanoecotoxicology. Toxicology 2010, 269:105-119.
39. Kandas N.O., Randolph C., Bosland M.C. Differential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrations. Nutr. Cancer 2009, 61:251-264.
40. Kawata K., Osawa M., Okabe S. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ. Sci. Technol. 2009, 43:6046-6051.
41. Kendig D.M., Tarloff J.B. Inactivation of lactate dehydrogenase by several chemicals: implications for in vitro toxicology studies. Toxicol. In Vitro 2007, 21:125-132.
42. Kim Y., Ha E.H., Park H., Ha M., Hong Y.C., Kim E.J., Kim B.N. Prenatal lead and cadmium co-exposure and infant neurodevelopment at 6 months of age: the mothers and children's environmental health (MOCEH) study. Neurotoxicology 2013, 35:15-22.
43. Koch P., Opitz T., Steinbeck J.A., Ladewig J., Brustle O. A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:3225-3230.
44. Kumar A., Pandey A.K., Singh S.S., Shanker R., Dhawan A. Engineered ZnO and TiO(2) nanoparticles induce oxidative stress and DNA damage leading to reduced viability of Escherichia coli. Free Radic. Biol. Med. 2011, 51:1872-1881.
45. Kumar K.K., Aboud A.A., Bowman A.B. The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk. Neurotoxicology 2012, 33:518-529.
46. Leblond C.S., Nava C., Polge A., Gauthier J., Huguet G., Lumbroso S., Giuliano F., Stordeur C., Depienne C., Mouzat K., Pinto D., Howe J., Lemiere N., Durand C.M., Guibert J., Ey E., Toro R., Peyre H., Mathieu A., Amsellem F., Rastam M., Gillberg I.C., Rappold G.A., Holt R., Monaco A.P., Maestrini E., Galan P., Heron D., Jacquette A., Afenjar A., Rastetter A., Brice A., Devillard F., Assouline B., Laffargue F., Lespinasse J., Chiesa J., Rivier F., Bonneau D., Regnault B., Zelenika D., Delepine M., Lathrop M., Sanlaville D., Schluth-Bolard C., Edery P., Perrin L., Tabet A.C., Schmeisser M.J., Boeckers T.M., Coleman M., Sato D., Szatmari P., Scherer S.W., Rouleau G.A., Betancur C., Leboyer M., Gillberg C., Delorme R., Bourgeron T. Meta-analysis of SHANK mutations in autism spectrum disorders: a gradient of severity in cognitive impairments. PLoS Genet. 2014, 10.
47. Linkov I., Satterstrom F.K., Corey L.M. Nanotoxicology and nanomedicine: making hard decisions. Nanomedicine 2008, 4:167-171.
48. Liu D.Z., Tian Y., Ander B.P., Xu H., Stamova B.S., Zhan X., Turner R.J., Jickling G., Sharp F.R. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J. Cereb. Blood Flow Metab. 2010, 30:92-101.
49. Luther E.M., Schmidt M.M., Diendorf J., Epple M., Dringen R. Upregulation of metallothioneins after exposure of cultured primary astrocytes to silver nanoparticles. Neurochem. Res. 2012, 37:1639-1648.
50. Marchetto M.C., Brennand K.J., Boyer L.F., Gage F.H. Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises. Hum. Mol. Genet. 2011, 20:R109-R115.
51. Marques R.C., Dorea J.G., Bernardi J.V., Bastos W.R., Malm O. Prenatal and postnatal mercury exposure, breastfeeding and neurodevelopment during the first 5 years. Cogn. Behav. Neurol. 2009, 22:134-141.
52. Medina C., Santos-Martinez M.J., Radomski A., Corrigan O.I., Radomski M.W. Nanoparticles: pharmacological and toxicological significance. Br. J. Pharmacol. 2007, 150:552-558.
53. Meng H., Xia T., George S., Nel A.E. A predictive toxicological paradigm for the safety assessment of nanomaterials. ACS Nano 2009, 3:1620-1627.
54. Min K.S. Physiological significance of metallothionein in oxidative stress. Yakugaku Zasshi 2007, 127:695-702.
55. Pal R., Mamidi M.K., Das A.K., Bhonde R. Human embryonic stem cell proliferation and differentiation as parameters to evaluate developmental toxicity. J. Cell. Physiol. 2011, 226:1583-1595.
56. Park M.V., Neigh A.M., Vermeulen J.P., de la Fonteyne L.J., Verharen H.W., Briede J.J., van Loveren H., de Jong W.H. The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials 2011, 32:9810-9817.
57. Peters A., von Klot S., Heier M., Trentinaglia I., Hormann A., Wichmann H.E., Lowel H. Exposure to traffic and the onset of myocardial infarction. N. Engl. J. Med. 2004, 351:1721-1730.
58. Powers C.M., Wrench N., Ryde I.T., Smith A.M., Seidler F.J., Slotkin T.A. Silver impairs neurodevelopment: studies in PC12 cells. Environ. Health Perspect. 2010, 118:73-79.
59. Rahman M.F., Wang J., Patterson T.A., Saini U.T., Robinson B.L., Newport G.D., Murdock R.C., Schlager J.J., Hussain S.M., Ali S.F. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol. Lett. 2009, 187:15-21.
60. Rosas-Hernandez H., Jimenez-Badillo S., Martinez-Cuevas P.P., Gracia-Espino E., Terrones H., Terrones M., Hussain S.M., Ali S.F., Gonzalez C. Effects of 45-nm silver nanoparticles on coronary endothelial cells and isolated rat aortic rings. Toxicol. Lett. 2009, 191:305-313.
61. Rosso S.B., Inestrosa N.C. WNT signaling in neuronal maturation and synaptogenesis. Front. Cell. Neurosci. 2013, 7:103.
62. Saha K., Jaenisch R. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 2009, 5:584-595.
63. Sahu S.C., Zheng J., Yourick J.J., Sprando R.L., Gao X. Toxicogenomic responses of human liver HepG2 cells to silver nanoparticles. J. Appl. Toxicol.: JAT 2015, 35:1160-1168.
64. Sharma H.S., Sharma A. Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology. Prog. Brain Res. 2007, 162:245-273.
65. Sharma H.S., Sharma A. Neurotoxicity of engineered nanoparticles from metals. CNS Neurol. Disord. Drug Targets 2012, 11:65-80.
66. Steiniger S.C., Kreuter J., Khalansky A.S., Skidan I.N., Bobruskin A.I., Smirnova Z.S., Severin S.E., Uhl R., Kock M., Geiger K.D., Gelperina S.E. Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int. J. Cancer 2004, 109:759-767.
67. Takenaka S., Karg E., Roth C., Schulz H., Ziesenis A., Heinzmann U., Schramel P., Heyder J. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ. Health Perspect. 2001, 109(Suppl. 4):547-551.
68. van Delft J.H., Mathijs K., Staal Y.C., van Herwijnen M.H., Brauers K.J., Boorsma A., Kleinjans J.C. Time series analysis of benzo[A]pyrene-induced transcriptome changes suggests that a network of transcription factors regulates the effects on functional gene sets. Toxicol. Sci. 2010, 117:381-392.
69. Voronova A., Fischer A., Ryan T., Al Madhoun A., Skerjanc I.S. Ascl1/Mash1 is a novel target of Gli2 during Gli2-induced neurogenesis in P19 EC cells. PLoS One 2011, 6.
70. Wang F., Jiao C., Liu J., Yuan H., Lan M., Gao F. Oxidative mechanisms contribute to nanosize silican dioxide-induced developmental neurotoxicity in PC12 cells. Toxicol. In Vitro 2011, 25:1548-1556.
71. Wang K., Zhang S., Marzolf B., Troisch P., Brightman A., Hu Z., Hood L.E., Galas D.J. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:4402-4407.
72. Wang X.J., Yang J., Cang H., Zou Y.Q., Yi J. Gene expression alteration during redox-dependent enhancement of arsenic cytotoxicity by emodin in HeLa cells. Cell Res. 2005, 15:511-522.
73. Winkler J., Sotiriadou I., Chen S., Hescheler J., Sachinidis A. The potential of embryonic stem cells combined with -omics technologies as model systems for toxicology. Curr. Med. Chem. 2009, 16:4814-4827.
74. Wobus A.M., Loser P. Present state and future perspectives of using pluripotent stem cells in toxicology research. Arch. Toxicol. 2011, 85:79-117.
75. Woo S.M., Kim J., Han H.W., Chae J.I., Son M.Y., Cho S., Chung H.M., Han Y.M., Kang Y.K. Notch signaling is required for maintaining stem-cell features of neuroprogenitor cells derived from human embryonic stem cells. BMC Neurosci. 2009, 10:97.
76. Wu J., Wang C., Sun J., Xue Y. Neurotoxicity of silica nanoparticles: brain localization and dopaminergic neurons damage pathways. ACS Nano 2011, 5:4476-4489.
77. Xia T., Kovochich M., Brant J., Hotze M., Sempf J., Oberley T., Sioutas C., Yeh J.I., Wiesner M.R., Nel A.E. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006, 6:1794-1807.
78. Xu L., Li X., Takemura T., Hanagata N., Wu G., Chou L.L. Genotoxicity and molecular response of silver nanoparticle (NP)-based hydrogel. J. Nanobiotechnol. 2012, 10:16.
79. Xu L., Takemura T., Xu M., Hanagata N. Toxicity of silver nanoparticles as assessed by global gene expression analysis. Mater. Express 2011, 1:74-79.
80. Zhang B., Pan X. RDX induces aberrant expression of microRNAs in mouse brain and liver. Environ. Health Perspect. 2009, 117:231-240.